Jennifer Sims‐Mourtada

1.3k total citations
34 papers, 1.0k citations indexed

About

Jennifer Sims‐Mourtada is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jennifer Sims‐Mourtada has authored 34 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 13 papers in Molecular Biology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jennifer Sims‐Mourtada's work include Hedgehog Signaling Pathway Studies (9 papers), Cancer Cells and Metastasis (8 papers) and Epigenetics and DNA Methylation (7 papers). Jennifer Sims‐Mourtada is often cited by papers focused on Hedgehog Signaling Pathway Studies (9 papers), Cancer Cells and Metastasis (8 papers) and Epigenetics and DNA Methylation (7 papers). Jennifer Sims‐Mourtada collaborates with scholars based in United States, Netherlands and Japan. Jennifer Sims‐Mourtada's co-authors include K. Arnold, K. S. Clifford Chao, Julie Izzo, Jaffer A. Ajani, Lynn M. Opdenaker, Daniel C. Flynn, Firas Mourtada, Daniel L. Smith, Adam Raben and Yan Yu and has published in prestigious journals such as Genes & Development, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Jennifer Sims‐Mourtada

32 papers receiving 1.0k citations

Peers

Countries citing papers authored by Jennifer Sims‐Mourtada

Since Specialization

Citations

This map shows the geographic impact of Jennifer Sims‐Mourtada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Sims‐Mourtada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Sims‐Mourtada more than expected).

Fields of papers citing papers by Jennifer Sims‐Mourtada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Sims‐Mourtada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Sims‐Mourtada. The network helps show where Jennifer Sims‐Mourtada may publish in the future.

Co-authorship network of co-authors of Jennifer Sims‐Mourtada

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Sims‐Mourtada. A scholar is included among the top collaborators of Jennifer Sims‐Mourtada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Sims‐Mourtada. Jennifer Sims‐Mourtada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer 2025 ·Genes & Development ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Julia I-Ju Leu, (unknown), Anne‐Marie Mes‐Masson, Jennifer Sims‐Mourtada, Noam Auslander, Ronny Drapkin, Benjamin G. Bitler, Nan Zhang, Maureen E. Murphy	1
2	B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer 2025 ·Scientific Reports ·(unknown), Lynn M. Opdenaker, (unknown), (unknown), Aihui Ma, (unknown), (unknown), Jennifer Sims‐Mourtada	3
3	CRISPR/Cas9 Targeting of Aldehyde Dehydrogenase 1A1 Reveals Heterogeneous Roles in Radiation Response and Redox Stress Across Clonal Lines in Triple-Negative Breast Cancer 2025 ·International Journal of Molecular Sciences ·(unknown), Aihui Ma, (unknown), Lynn M. Opdenaker, Jennifer Sims‐Mourtada	0
4	Optimization Processes of Clinical Chelation-Based Radiopharmaceuticals for Pathway-Directed Targeted Radionuclide Therapy in Oncology 2024 ·Pharmaceutics ·(unknown), (unknown), Firas Mourtada, Jennifer Sims‐Mourtada, (unknown), (unknown), David J. Yang, Tomio Inoue	1
5	Neighborhood factors and triple negative breast cancer: The role of cumulative exposure to area‐level risk factors 2023 ·Cancer Medicine ·Scott D. Siegel, (unknown), Jesse D. Berman, Shannon M. Lynch, Jennifer Sims‐Mourtada, Zachary T. Schug, Frank C. Curriero	11
6	Actinium-225 Targeted Agents: Where Are We Now? 2023 ·Brachytherapy ·Firas Mourtada, (unknown), Jennifer Sims‐Mourtada, (unknown), (unknown), (unknown), Taro Murai, David J. Yang, Tomio Inoue	13
7	Tumor-B-cell interactions promote isotype switching to an immunosuppressive IgG4 antibody response through upregulation of IL-10 in triple negative breast cancers 2022 ·Journal of Translational Medicine ·(unknown), Lynn M. Opdenaker, (unknown), (unknown), (unknown), (unknown), (unknown), Rajasekharan Somasundaram, Jennifer Sims‐Mourtada	19
8	Racial disparities in triple negative breast cancer: toward a causal architecture approach 2022 ·Breast Cancer Research ·Scott D. Siegel, (unknown), Shannon M. Lynch, Jennifer Sims‐Mourtada, Zachary T. Schug, Frank C. Curriero	20
9	Fatty acid synthase as a feasible biomarker for triple negative breast cancer stem cell subpopulation cultured on electrospun scaffolds 2021 ·Materials Today Bio ·Marc Rabionet, (unknown), Joana Relat, Marc Yeste, Jennifer Sims‐Mourtada, April M. Kloxin, Marta Planas, Lídia Feliu, Joaquim Ciurana, Teresa Puig	15
10	Dosimetric Characterization of an Abscopal Response in a Patient With Oligometastatic Melanoma Undergoing Concurrent Treatment With Pembrolizumab and Stereotactic Body Radiotherapy (SBRT) 2018 ·Jennifer Sims‐Mourtada, (unknown), David Huang, (unknown), Sunjay Shah, (unknown), Adam Raben, Firas Mourtada	4
11	The Multifaceted Roles of B Cells in Solid Tumors: Emerging Treatment Opportunities 2017 ·Targeted Oncology ·(unknown), Rajasekharan Somasundaram, K. Arnold, Jennifer Sims‐Mourtada	31
12	Obesity and Breast Cancer: Do Age, Race and Subtype Matter? 2016 ·PubMed Central ·K. Arnold, (unknown), Jennifer Sims‐Mourtada	1
13	Long Term, Low Dose Genistein decreases Stem Cell Populations and Sensitizes Inflammatory Breast Cancer Cell Lines to Radiation 2015 ·Jennifer Sims‐Mourtada, Lynn M. Opdenaker, Joshua Davis, Changqing Wu	4
14	Activation of Inflammatory Responses Correlate With Hedgehog Activation and Precede Expansion of Cancer Stem-Like Cells in an Animal Model of Residual Triple Negative Breast Cancer after Neoadjuvant Chemotherapy 2015 ·PubMed ·K. Arnold, (unknown), Jennifer Sims‐Mourtada	7
15	Patched Targeting Peptides for Imaging and Treatment of Hedgehog Positive Breast Tumors 2014 ·BioMed Research International ·Daniel L. Smith, Fanlin Kong, David J. Yang, Richard Larson, Jennifer Sims‐Mourtada, Wendy A. Woodward	6
16	Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer 2014 ·Breast Cancer Targets and Therapy ·Jennifer Sims‐Mourtada, (unknown), K. Arnold, Ryan T. Pohlig, Daniel C. Flynn, (unknown)	13
17	Enrichment of breast cancer stem-like cells by growth on electrospun polycaprolactone-chitosan nanofiber scaffolds 2014 ·International Journal of Nanomedicine ·Jennifer Sims‐Mourtada, (unknown), Shani Samuel, (unknown), Eric B. Kmiec	58
18	The untapped potential of Gallium 68-PET: The next wave of 68Ga-agents 2012 ·Applied Radiation and Isotopes ·Daniel L. Smith, Wouter A.P. Breeman, Jennifer Sims‐Mourtada	46
19	Safety and Efficacy of Radionuclide Therapy with High-Activity In-111 Pentetreotide in Patients with Progressive Neuroendocrine Tumors 2008 ·Cancer Biotherapy and Radiopharmaceuticals ·Ebrahim S. Delpassand, Jennifer Sims‐Mourtada, Hitomi Saso, Ali Azhdarinia, Faramarz Ashoori, (unknown), Gregory D. Espenan, Warren H. Moore, Eugene A. Woltering, Lowell Anthony	40
20	Targeting the Hedgehog Pathway to Mitigate Treatment Resistance 2007 ·Cell Cycle ·Yu-Jen Chen, Jennifer Sims‐Mourtada, Julie Izzo, K. S. Clifford Chao	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact